[Home ] [Archive]    
:: Volume 3, Issue 2 (June 2018) ::
jogcr 2018, 3(2): 0-0 Back to browse issues page
Neoadjuvant Chemotherapy in Cervical Cancer: A Review Article
Elham Shirali *1, Fariba Yarandi1, Nadereh Behtash1, Omid Hemmatian1
1- Gynecology & Oncology Department, School of Medicine, Tehran University of Medical Science, Tehran, Iran
Abstract:   (400 Views)
Aims Cervical cancer is one of the most common cancer in the female since 1990. Neoadjuvant chemotherapy (NACT) uses before surgery, especially in countries with limited radiotherapy facilities. The aim of the present review was to study the effect of NACT before radical surgery in comparison with other treatments and various clinical outcomes.
Information and Methods This study is a systematic review and includes previous publishes about cervical cancer and effect of NACT before radical surgery. Over 40 previous studies were reviewed, none of them was case report, at least 5 studies were randomized clinical trials and 6 of them were meta-analysis or systematic review.
Findings NACT before surgery demonstrates advantages to reduce the rate of lymph node metastasis and parametrial infiltration, so improves progression-free survival in patients with pelvic lymph node invasion (Approximately 35% of stage IB2–IIB bulky). NACT also decreases tumor volume and minimizes the need for adjuvant radiotherapy, thus NACT under consideration of quality of life and cost-effectiveness should be recommended. NACT is really effective in decreasing incidence of pathological risk factors.
Conclusion NACT response associated with the stage of diagnosis, tumor size and pathology of the specimen (Squamous tumor has a better response than a non-squamous tumor). NACT seems to be feasible in the management of stage IB bulky cervical cancer, NACT followed by surgery represent an alternative to primary chemoradiotherapy in young and sexually active patients.
Keywords: Adjuvant Chemotherapy, Cervical Cancer, Chemoradiotherapy, Neoplasm Me tastasis, Adenocarcinoma
Full-Text [PDF 418 kb]   (151 Downloads)    
Systematic Review: Original Research | Subject: General
Received: 2018/12/29 | Accepted: 2018/12/29 | Published: 2018/12/29
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA code


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shirali E, Yarandi F, Behtash N, Hemmatian O. Neoadjuvant Chemotherapy in Cervical Cancer: A Review Article. jogcr. 2018; 3 (2)
URL: http://jogcr.com/article-1-201-en.html


Volume 3, Issue 2 (June 2018) Back to browse issues page
Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 3897